Cargando…
Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection
The gut microbiota plays a critical role in the induction of adaptive immune responses to influenza virus infection. However, the role of nasal bacteria in the induction of the virus-specific adaptive immunity is less clear. Here, we found that disruption of nasal bacteria by intranasal application...
Autores principales: | Nagai, Minami, Moriyama, Miyu, Ichinohe, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406166/ https://www.ncbi.nlm.nih.gov/pubmed/34399617 http://dx.doi.org/10.1128/mBio.01598-21 |
Ejemplares similares
-
Influenza Virus-Induced Oxidized DNA Activates Inflammasomes
por: Moriyama, Miyu, et al.
Publicado: (2020) -
Influenza A virus M2 protein triggers mitochondrial DNA-mediated antiviral immune responses
por: Moriyama, Miyu, et al.
Publicado: (2019) -
High body temperature increases gut microbiota-dependent host resistance to influenza A virus and SARS-CoV-2 infection
por: Nagai, Minami, et al.
Publicado: (2023) -
Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses
por: Hasegawa, Hideki, et al.
Publicado: (2009) -
Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys
por: Le Nouën, Cyril, et al.
Publicado: (2022)